30-Day Survival After Temporary Right Ventricular Assist Devices: A Systematic Review | ||
| Cardiovascular Research Prove Journal | ||
| Volume 6, Issue 1, June 2022 PDF (200.14 K) | ||
| Document Type: Abstracts | ||
| DOI: 10.21608/cvrepj.2022.351455 | ||
| Abstract | ||
| Acute right-sided heart failure (RHF) is a complex clinical syndrome, with a wide range of clinical presentations, associated with increased mortality and morbidity, but with a scarcity of evidence-based literature. Temporary right ventricular assist device (t-RVAD) is a potential treatment option for selected patients with severe right ventricular dysfunction as a bridge-to-recovery or as a permanent solution. | ||
|
Statistics Article View: 68 PDF Download: 30 |
||
